季刊
2096-6962
bh@cmaph.org
010-63586558
100034
北京市西城区迎新街100号
SevereSARS‐CoV‐2infectionPediatricpatientsRiskfactorRNAemiaBF.7.14
MedicinalfungiNaturalproductsAntiviralactivityCOVID‐19Polysaccharides
PoxvirusMpoxvirusVacciniavirusPersistenceDisinfectant
CoxsackievirusA6D3genotypeVirus‐likeparticleImmunoprotectiveeffect
NasopharyngealswabRT‐PCRSARS‐CoV‐2Surgicalmask
EscherichiacoliExtended‐spectrumβ‐lactamasesCTX‐M
Antimicrobialresistance(AMR)BacteriaSurveillanceOneHealthVaccinesAfrica